Equipoise Remains a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC

Affiliations

• ¹ Sydney Health Ethics, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Electronic address: shey0696@uni.sydney.edu.au.
• ² Department of Philosophy, Macquarie University, Sydney, Australia.
• ³ Department of Medical Oncology, St Vincent's Hospital, Melbourne, Australia; Department of Medicine, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.
• ⁴ Department of Medicine, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia; Department of Palliative Care, St Vincent's Hospital, Melbourne, Australia; Department of Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ⁵ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Melbourne, Australia.
• ⁶ Sydney Health Ethics, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Philosophy, Macquarie University, Sydney, Australia; Department of Haematology, Royal North Shore Hospital, Sydney, Australia.